RESOURCES

FEATURED PROJECTS

  • May 06, 2025
    Share

    Targeted B-Cell Therapies: Challenges and Preclinical Evaluation Considerations for Repurposing from Oncology to Autoimmunity

    While targeted therapies such as B-cell depletion and immune modulation have revolutionized treatment for B-cell malignancies, recent efforts to repurpose these therapies for autoimmune diseases, for example systemic lupus erythematosus (SLE), have gained traction. However, translating oncology-focused B-cell therapies to autoimmune diseases requires addressing fundamental differences in disease pathophysiology, therapeutic goals, and safety profiles. In this webinar, we will outline key challenges and preclinical evaluation considerations to help you navigate this cross-disciplinary transition.

Data request in progress, please wait…